Aquaculture Pharmaceuticals Market: By Product Type (Biologics, Parasiticides, Anti-infectives, Reproduction, and Others), By Species (Carps, Salmon, Tilapia, Shrimp, Catfish, Trout, and Others) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Aquaculture Pharmaceuticals Market size was valued at USD 874.3 million in 2022 and is anticipated to grow at a CAGR of 7.5 % over 2023-2029. Aquaculture pharmaceuticals, also known as aqua pharmaceuticals or aqua meds, refer to a class of substances used in the aquaculture industry to promote the health and well-being of aquatic animals, particularly those raised in fish farms or other controlled aquatic environments. Aquaculture pharmaceuticals play a crucial role in preventing, diagnosing, and treating diseases and health issues that can arise in farmed fish, shellfish, and other aquatic organisms.

The increasing global demand for seafood has a significant impact on driving the revenues of the aquaculture pharmaceuticals market. As the world's population continues to grow and dietary preferences evolve, the consumption of seafood is on the rise. To meet this demand, the aquaculture industry is expanding its production capacity. However, intensifying aquaculture operations can lead to challenges related to disease outbreaks, stress, and suboptimal health conditions for farmed aquatic species. Aquaculture pharmaceuticals play a pivotal role in ensuring the health and well-being of these species, enabling sustainable and responsible aquaculture practices. Moreover, regulatory requirements exert a substantial influence on driving the aquaculture pharmaceuticals market. As governments and international bodies place increased emphasis on responsible and sustainable aquaculture practices, regulations are put in place to ensure the health and welfare of farmed aquatic species and the surrounding environment. To comply with these requirements and maintain regulatory standards, aquaculture operators turn to aquaculture pharmaceuticals as essential tools for disease control, treatment, and overall health improvement.

However, stringent regulations and approval processes for aquaculture pharmaceuticals can slow down innovation and limit the availability of effective treatments, which eventually act as a major challenge to the growth of the aquaculture pharmaceuticals market. Meanwhile, the growth of intensive aquaculture practices, including fish farming and shrimp farming that require advanced pharmaceutical solutions, creates significant opportunities for further growth of the aquaculture pharmaceuticals market. Major pharmaceutical companies are developing innovative solutions to cater to the aquaculture industry. For instance, in October 2022, Indian Immunologicals ventured into aquaculture health by launching a product line encompassing various offerings such as vaccines to meet the rising demand for healthy farmed shrimp and fish in India.

Aquaculture Pharmaceuticals Market Key Developments:  
  • In April 2019, CZ Vaccines and Irish firm Marrinovak Ltd have launched the new aquaculture-focused pharmaceutical venture Aquatreck Animal Health.
  • In June 2022, Aqua Pharma and Kytos collaborated to develop a precision dosing solution for shrimp farmers, SEATRU.
  • In January 2021, Proteon Pharmaceuticals S.A. partnered with Skretting to co-develop a new phage-based solution for aquaculture providing functional solutions to tackle health challenges in the aquaculture industry.

Aquaculture Pharmaceuticals Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

7.5%

Largest Market

Asia Pacific

Fastest Growing Market

Asia Pacific
Aquaculture Pharmaceuticals Market Dynamics

Pharmaceuticals plays a pivotal role in aquaculture to prevent and treat aquatic animals from various microbial infections. Companies are betting heavily on research and development programs to develop novel drugs that can treat new infections in aquatic animals. For instance, in 2015, PHARMAQ, a part of Zoetis, Inc., invested in to produce fish vaccines in new facility at Klofta. Furthermore, lack of generic drugs to compete with inventor drugs makes more lucrative for the aquaculture pharmaceuticals manufacturers. In addition, global increase in farmed fish production than the wild catch are projected to boost aquaculture pharmaceuticals market over the forecast period. According to Food and Agriculture Organisation of the United Nations (FAO) estimates, the farmed fish production increased by 5.6% from 66.5 Mn tonnes (2013) to 70.2 Mn tonnes (2013).

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Aquaculture Pharmaceuticals Market Segmentation

By Product
  • Biologics
  • Parasiticides
  • Anti-infectives
  • Reproduction
  • Others
By Species
  • Carps
  • Salmon
  • Tilapia
  • Shrimp
  • Catfish
  • Trout
  • Others
By Geography
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Frequently Asked Questions

The aquaculture pharmaceuticals market size was valued at USD 874.3 million in 2022

Elanco (Eli Lilly and Company) (U.S), Intervet Inc., (Merck & Co., Inc.,) (U.S.), Bayer AG (Germany), PharmaQ AS (Zoetis, Inc

North America is the fastest-growing region for aquaculture pharmaceuticals market

Innovation in pharmaceuticals and investment in research and development of new aquaculture pharmaceuticals are some of the key opportunities for companies to enhance their revenue over the forecast years.

Innovations in delivery methods for aquaculture pharmaceuticals and integration of remote health monitoring systems are some of the major trends in the aquaculture pharmaceuticals market.

 

1. Executive Summary
2. Global Aquaculture Pharmaceuticals Market Introduction 
2.1.Global Aquaculture Pharmaceuticals Market  - Taxonomy
2.2.Global Aquaculture Pharmaceuticals Market  - Definitions
2.2.1.Product
2.2.2.Species
2.2.3.Geography
2.2.4.Region
3. Global Aquaculture Pharmaceuticals Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Aquaculture Pharmaceuticals Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Aquaculture Pharmaceuticals Market  By Product, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Biologics
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Parasiticides
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Anti-infectives
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Reproduction
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Others
5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6. Global Aquaculture Pharmaceuticals Market  By Species, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Carps
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Salmon
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Tilapia
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Shrimp
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Catfish
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Trout
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Others
6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
7. Global Aquaculture Pharmaceuticals Market  By Geography, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia-Pacific
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Latin America
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Middle East and Africa (MEA)
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8. Global Aquaculture Pharmaceuticals Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Aquaculture Pharmaceuticals Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Product Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Biologics
9.1.2.Parasiticides
9.1.3.Anti-infectives
9.1.4.Reproduction
9.1.5.Others
9.2.  Species Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Carps
9.2.2.Salmon
9.2.3.Tilapia
9.2.4.Shrimp
9.2.5.Catfish
9.2.6.Trout
9.2.7.Others
9.3.  Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.North America
9.3.2.Europe
9.3.3.Asia-Pacific
9.3.4.Latin America
9.3.5.Middle East and Africa (MEA)
9.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Aquaculture Pharmaceuticals Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Biologics
10.1.2.Parasiticides
10.1.3.Anti-infectives
10.1.4.Reproduction
10.1.5.Others
10.2.  Species Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Carps
10.2.2.Salmon
10.2.3.Tilapia
10.2.4.Shrimp
10.2.5.Catfish
10.2.6.Trout
10.2.7.Others
10.3.  Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.North America
10.3.2.Europe
10.3.3.Asia-Pacific
10.3.4.Latin America
10.3.5.Middle East and Africa (MEA)
10.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11. Asia Pacific (APAC) Aquaculture Pharmaceuticals Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Biologics
11.1.2.Parasiticides
11.1.3.Anti-infectives
11.1.4.Reproduction
11.1.5.Others
11.2.  Species Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Carps
11.2.2.Salmon
11.2.3.Tilapia
11.2.4.Shrimp
11.2.5.Catfish
11.2.6.Trout
11.2.7.Others
11.3.  Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.North America
11.3.2.Europe
11.3.3.Asia-Pacific
11.3.4.Latin America
11.3.5.Middle East and Africa (MEA)
11.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Aquaculture Pharmaceuticals Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Biologics
12.1.2.Parasiticides
12.1.3.Anti-infectives
12.1.4.Reproduction
12.1.5.Others
12.2.  Species Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Carps
12.2.2.Salmon
12.2.3.Tilapia
12.2.4.Shrimp
12.2.5.Catfish
12.2.6.Trout
12.2.7.Others
12.3.  Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.North America
12.3.2.Europe
12.3.3.Asia-Pacific
12.3.4.Latin America
12.3.5.Middle East and Africa (MEA)
12.4.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Aquaculture Pharmaceuticals Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Product Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Biologics
13.1.2.Parasiticides
13.1.3.Anti-infectives
13.1.4.Reproduction
13.1.5.Others
13.2.  Species Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Carps
  • Elanco (Eli Lilly and Company) (U.S.)
  • Intervet Inc., (Merck & Co., Inc.,) (U.S.)
  • Bayer AG (Germany)
  • PharmaQ AS (Zoetis, Inc.,)

Adjacent Markets